Kim Jung Kwon, Moon Kyung Chul, Jeong Chang Wook, Kwak Cheol, Kim Hyun Hoe, Ku Ja Hyeon
Department of Urology, Center for Prostate Cancer, Research Institute and Hospital of the National Cancer Center, Goyang, Korea.
Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea.
Urol Oncol. 2017 Jul;35(7):458.e9-458.e15. doi: 10.1016/j.urolonc.2017.02.010. Epub 2017 Mar 24.
To investigate the effect of variant histology (VH) on survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma (UTUC) and the effect of adjuvant chemotherapy on the survival of patients with UTUC with VH.
A total of 452 patients who underwent radical nephroureterectomy for UTUC without neoadjuvant chemotherapy in our institution between 1991 and 2012 were retrospectively analyzed. We performed a comparative analysis between pure UTUC and UTUC with VH groups. The Kaplan-Meier method was used to calculate survival estimates for cancer-specific survival (CSS) and overall survival (OS), and log-rank test was used to conduct comparisons between the groups. Univariate and multivariate Cox-proportional hazard regression analyses were performed to evaluate significant variables associated with CSS and OS.
UTUC with VH was present in 41 (9.1%) patients. UTUC with VH showed aggressive clinicopathological features in comparison with pure UTUC. The Kaplan-Meier curves showed significantly decreased 5-year CSS and OS (both, P<0.001) in UTUC with VH group. Multivariate analysis revealed that VH was an independent predictor of CSS (P<0.001) and OS (P<0.002). The Kaplan-Meier curves also showed significantly decreased 5-year CSS and OS in UTUC with the VH group compared to the pure UTUC group in patients who received adjuvant chemotherapy.
We found that UTUC with VH harbored aggressive biologic features, and VH was an independent prognostic factor for CSS and OS on both univariate and multivariate analyses. In addition, UTUC with VH group had poorer survival outcomes than pure UTUC group in patients who received adjuvant chemotherapy. Consequently, adjuvant treatment modalities other than adjuvant chemotherapy should be considered in this group.
探讨组织学变异(VH)对上尿路尿路上皮癌(UTUC)患者根治性肾输尿管切除术后生存的影响,以及辅助化疗对UTUC伴VH患者生存的影响。
回顾性分析1991年至2012年间在本机构接受根治性肾输尿管切除术且未接受新辅助化疗的452例UTUC患者。我们对单纯UTUC组和UTUC伴VH组进行了对比分析。采用Kaplan-Meier法计算癌症特异性生存(CSS)和总生存(OS)的生存估计值,并使用对数秩检验进行组间比较。进行单因素和多因素Cox比例风险回归分析,以评估与CSS和OS相关的显著变量。
41例(9.1%)患者存在UTUC伴VH。与单纯UTUC相比,UTUC伴VH表现出侵袭性的临床病理特征。Kaplan-Meier曲线显示,UTUC伴VH组的5年CSS和OS显著降低(均为P<0.001)。多因素分析显示,VH是CSS(P<0.001)和OS(P<0.002)的独立预测因素。在接受辅助化疗的患者中,Kaplan-Meier曲线还显示,UTUC伴VH组的5年CSS和OS与单纯UTUC组相比显著降低。
我们发现UTUC伴VH具有侵袭性生物学特征,且VH在单因素和多因素分析中均是CSS和OS的独立预后因素。此外,在接受辅助化疗的患者中,UTUC伴VH组的生存结果比单纯UTUC组更差。因此,对于该组患者应考虑采用辅助化疗以外的辅助治疗方式。